Matarin Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Matarin Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-117,870	Closed	-$5.35M	–	257
2019 Q4	$5.35M	Sell	117,870 -79,717	-40%	-$3.77M	0.51%	85
2019 Q3	$9.04M	Sell	197,587 -9,023	-4%	-$507K	0.68%	63
2019 Q2	$12.1M	Buy	+206,610	New	+$10.7M	0.87%	36

Other funds holding ARNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Matarin Capital Management's ARNA Position: Q1 2020 in Review

Matarin Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 117,870 shares — an estimated $5.35M sold.

Matarin Capital Management first reported a position in ARNA in Q2 2019 and held it in 3 quarters. The position peaked at $12.1M in Q2 2019. 218 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

Matarin Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
Matarin Capital Management sold 117,870 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $5.35M.
Matarin Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 3 quarters.
Matarin Capital Management's Arena Pharmaceuticals Inc position peaked at $12.1M in Q2 2019.
218 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on Matarin Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.